CDC Alters Hepatitis B Vaccine Guidance; Coverage Remains Unchanged

Parents will continue to receive the hepatitis B vaccine for their children at no cost despite recent changes in immunization recommendations from the U.S. Centers for Disease Control and Prevention (CDC). On October 20, 2023, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to modify its guidelines, ending the universal recommendation for hepatitis B vaccination in newborns.

The new guidelines suggest that mothers who test negative for the virus should consult with a healthcare provider before vaccinating their infants. This shift may create confusion and potentially lead to a decrease in the number of vaccinated children. In addition, the advisory committee recommended that infants who do not receive the vaccine at birth should wait at least two months before getting vaccinated.

In response to these changes, two major health insurance organizations, the Blue Cross Blue Shield Association and America’s Health Insurance Plans (AHIP), affirmed their commitment to covering all vaccines recommended by ACIP without cost-sharing through 2026. A spokesperson for BCBSA stated that coverage would extend to all immunizations recommended by ACIP as of January 1, 2025, while adhering to federal and state laws.

AHIP confirmed that its members would cover all vaccines recommended by ACIP as of September 1, 2025. Both organizations had previously released statements regarding their coverage policies before ACIP’s announcement of changes to other vaccines, including the COVID-19 and combined measles, mumps, rubella, and varicella (MMRV) vaccines.

Concerns arose regarding the requirement for healthcare consultations, as it could lead to uncertainty about whether insurers would continue to cover the full cost of vaccinations. The Affordable Care Act mandates that most private insurers cover vaccines recommended by ACIP at no cost, and Medicaid’s coverage is also tied to these recommendations.

Jen Kates, senior vice president of global and public health policy for the Kaiser Family Foundation (KFF), an independent health policy research organization, clarified that the shift to shared clinical decision-making would not impact the ACA’s insurance coverage mandate. She noted, “The change today will have an impact, but not on insurance coverage.” Instead, the primary consequence would likely be a reduction in the number of newborns receiving the vaccine.

ACIP also voted to recommend shared clinical decision-making for parents accessing free vaccines through the Vaccines for Children program, which provides immunizations at no cost to eligible children, including those on Medicaid or who are uninsured. Dr. Georgina Peacock, director of the CDC’s Immunization Services Division, indicated that if approved, these immunizations would remain covered under the program.

A representative from the Centers for Medicare and Medicaid Services also assured that the inclusion of individual-based decision-making language would not alter the cost-sharing requirements for the hepatitis B vaccine. While the CDC typically aligns its final vaccine recommendations with the advisory panel’s votes, the recent changes underscore the evolving landscape of immunization practices in the United States.

As parents navigate these new recommendations, clarity surrounding vaccine availability and coverage remains critical for ensuring the health and safety of children across the country.